<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">We promote the use of the HCQ to match that of the standard treatment of Systemic Lupus erythematous which has proven safety and efficacy in terms of HCQ blood and tissue concentration adapted to bodyweight [
 <xref rid="bb0010" ref-type="bibr">2</xref>,
 <xref rid="bb0015" ref-type="bibr">3</xref>], at 6 mg/kg/day 1 (loading dose) followed by 5 mg/kg/day, with a maximum limit of 600 mg/day in all cases. The duration of the post-exposure regimen should last as long as the contact with a positive patient last or in case of repeated exposure, with a minimum of 10 days to reach a blood concentration at steady state. The terminal elimination half-life is approximately 50 days [
 <xref rid="bb0020" ref-type="bibr">4</xref>] leading to a long term efficacy.
</p>
